Key result
SLC2A10 c.243C>G mutation in Arterial Tortuosity Syndrome links to mild outcomes and 0% mortality.
Why the study?
The full clinical spectrum and disease course of Arterial Tortuosity Syndrome remain incompletely understood.
Cohort (n=21)
The SLC2A10 p.Ser81Arg mutation in Qatari patients with Arterial Tortuosity Syndrome is associated with a mild clinical course without mortality but presents with several novel systemic features.
Answers are grounded in this paper and cite their sources.
Mild course without mortality observed in this Qatari ATS cohort; extends phenotypic spectrum but leaves generalizability open.
Background/Objectives: Arterial Tortuosity Syndrome (ATS) is a rare, autosomal recessive connective tissue disorder characterized by arterial twists, abnormal bulges, constriction, and tears. Patients have distinctive features and disease manifestations. The syndrome’s full clinical spectrum and course remain incompletely understood. Methods: We sought to review the medical records of Qatari patients who had ATS. The cohort study included 21 patients who were genetically confirmed by mutations in the SLC2A10 gene. Results: The study revealed that the NM_030777.4(SLC2A10):c.243C>G (p.Ser81Arg) mutation in SLC2A10 leads to mild outcomes of no mortality and less morbidity. Novel features such as a flat philtrum, bulbous noses, bilateral nasolacrimal duct obstruction, allergic conjunctivitis, latent nystagmus, café au lait spots, eczema, dermatitis, allergic reactions, bilateral temporomandibular joint cysts, bilateral syndactyly (toes), parapelvic cysts, kidney malrotation, vesicoureteral reflux, and nephrolithiasis were identified in our cohort. Furthermore, rare features previously documented in a limited number of patients, including leg length discrepancy, epilepsy, and migraine headaches, were also observed in our cohort. Conclusions: Our data contributes new insights into the life course of ATS in Qatari patients. These findings underscore the importance of effective education strategies through repeated counseling aimed at preventing cousin marriage and the syndrome within the cohort.
No takes yet. Share an insight, caveat, or question.
Rahmath et al. (2025) conducted a cohort in Arterial Tortuosity Syndrome (ATS) (n=21). SLC2A10 c.243C>G (p.Ser81Arg) mutation was evaluated on Clinical outcomes and novel features. The SLC2A10 c.243C>G (p.Ser81Arg) mutation in 21 Qatari patients with Arterial Tortuosity Syndrome was associated with mild outcomes including no mortality and novel clinical features.
Synapse has enriched 10 related papers. Consider them for comparative context: